# Immunochemotherapy, Zevalin, and Bone Marrow Transplant for Follicular Lymphoma

> **NCT01130194** · PHASE2 · COMPLETED · sponsor: **St. Louis University** · enrollment: 29 (actual)

## Conditions studied

- Follicular Lymphoma

## Interventions

- **OTHER:** Combination of treatment modalities

## Key facts

- **NCT ID:** NCT01130194
- **Lead sponsor:** St. Louis University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-07
- **Primary completion:** 2012-06
- **Final completion:** 2012-06
- **Target enrollment:** 29 (ACTUAL)
- **Last updated:** 2014-05-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01130194

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01130194, "Immunochemotherapy, Zevalin, and Bone Marrow Transplant for Follicular Lymphoma". Retrieved via AI Analytics 2026-07-09 from https://api.ai-analytics.org/clinical/NCT01130194. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*